Berry e-liquid flavour toxicities are not equal on an alveolar-capillary barrier cell model according to two exposure methods.

阅读:2
作者:Filaudeau Emma, Sabo Amelia-Naomi, Lebert Anita, Monassier Laurent, Kemmel Véronique
E-cigarettes are often presented as a smoking cessation tool, less harmful than tobacco and are now a regular feature of everyday life. However, the fruity and sweet flavours are attractive to teenagers who can use them recreationnaly. The main risk of this phenomenon is becoming trapped in nicotine addiction. Although e-liquids, which combine nicotine, humectants and flavouring agents, seem to affect the pulmonary system and in particular the alveolar-capillary barrier (ACB), data on nicotine-free e-liquids remain scarce. The aim of this work is to study the toxicity of nicotine-free e-liquids/aerosols flavoured with berries (Strawberry, Raspberry, Blackberry, Blueberry) using two exposure methods. First, we validated an in vitro model of the ACB using epithelial NCI-H441 and endothelial EA.hy926 cells. Secondly, barrier integrity, production of oxidative species and cytotoxicity were assessed by transepithelial resistance (TER) measurement, MitoSOX® and LDH test, respectively, after exposure to two different methods: dilution of the e-liquid and aerosol trapping in the culture medium. Finally, a non-exhaustive analysis of the chemical compounds found in berry e-liquids was performed to identify potentially toxic compounds specific to certain flavours. The model mimicked phenotypically and functionally the ACB. The two exposure methods tested revealed significant differences in terms of e-liquid/aerosol toxicity on the ACB, probably due to variations in aromatic and degradation products. Flavours are not all equal in terms of cell toxicities, making it essential to chemically identify the compounds responsible for these different degrees of toxicity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。